Rapid NGS with Oncomine Assays on the Ion Torrent Genexus System

A direct route to complete oncology research biomarker results in as little as 24 hours.

 

When turnaround times define how your lab performs, speed must be measured across the entire workflow—not just individual steps. Oncomine Assays on the Ion Torrent Genexus System enable end-to-end rapid next-generation sequencing (NGS) with an automated sample-to-result workflow, integrated analysis, just two user touchpoints, and minimal hands-on time. From targeted solid tumor genomic profiling in as little as 24 hours to next-day comprehensive genomic profiling and streamlined myeloid profiling, the portfolio is designed to help laboratories move faster with confidence.


End-to-end automated NGS workflow for rapid results

Some solutions emphasize speed in only one part of the workflow, such as library preparation or sequencing. But one fast step is not the same as a fast route to report. Delivering rapid results requires the entire sample-to-report workflow to move efficiently—from nucleic acid extraction and quantification through library preparation, sequencing, analysis, and reporting.

 

Oncomine Assays on the Ion Torrent Genexus System are designed to keep every step on track with an automated sample-to-result workflow run within one integrated software environment. With just two user touchpoints, minimal hands-on time, and simplified operation, laboratories can accelerate reporting while reducing operational complexity—even when resources are limited or prior NGS experience is minimal.

End-to-end automation


From nucleic acid extraction and quantification through library preparation, sequencing, analysis, and report generation.

Fast
turnaround


Targeted profiling can deliver results in as little as 24 hours, while comprehensive genomic profiling can be delivered as fast as next day.

Minimal
hands-on-time


Two user touchpoints and as little as 20 minutes hands-on time in key workflows.

One-vendor
simplicity


Instruments, consumables, analysis, and support from a single source.

The Ion Torrent Genexus System is designed to integrate key workflow steps within one software environment, helping laboratories move from nucleic acid extraction and quantification through library preparation, sequencing, analysis, and reporting with minimal hands-on time.

Figure: Ion Torrent Genexus System NGS automated workflow.


Compare the Oncomine NGS assay menu

Oncomine Assays on the Ion Torrent Genexus System offer a flexible route for clinical oncology research—from deep analysis of one key gene to targeted panels, comprehensive genomic profiling for solid tumors, and hematology research applications. Whether the priority is rapid, cost-efficient profiling of key solid tumor biomarkers, broad genomic insight, or streamlined myeloid profiling in hemato-oncology research, the portfolio is designed to combine speed, automation, and relevant biomarker coverage in one end-to-end workflow.


These featured solutions highlight three distinct routes within the Oncomine portfolio: targeted profiling of solid tumor samples, next-day comprehensive genomic profiling, and streamlined myeloid profiling in hemato-oncology. Together, they show how laboratories can match assay depth to research need while staying within the same rapid, automated Genexus workflow.

Oncomine Precision Assay

The Oncomine Precision Assay (OPA) is a targeted NGS panel for fast and efficient profiling across key solid tumor biomarkers.

  • Multi-variant detection across 50 genes: Covers SNVs, indels, CNVs, and fusions in one assay
  • Rapid, automated workflow for in-house genomic profiling: Designed for automation and fast turnaround, ideal for labs prioritizing simplicity, low hands-on time, and operational efficiency.
  • Minimal sample required: Requires only 10 ng DNA or RNA input and is compatable with FFPE tissue and liquid biopsy profiling
  • Focused design for mid-tier profiling: Curated gene content and fast access to relevant biomarker information across multiple solid tumors without stepping up to a larger panel than needed

Oncomine Comprehensive Assay Plus

The Oncomine Comprehensive Assay Plus (OCA Plus) is a broad CGP (comprehensive genomic profiling) panel designed to deliver deep, multi-biomarker insights across tumor types, supporting advanced precision oncology research applications.

  • Extensive genomic coverage for comprehensive profiling: Detects SNVs, indels, CNVs, fusions, making it ideal for full CGP and complex case evaluation
  • Genomic signatures: Reports HRD, TMB and MSI genomic signatures
  • Fast turnaround time: Enables rapid next-day results delivery
  • Designed for advanced clinical research use: For tumor samples requiring comprehensive molecular insight, including advanced genomic signatures beyond the reach of smaller targeted assays, samples of unknown tumor origin, or cases where a smaller targeted panel yields negative results

Oncomine Myeloid Assay GX v2

The Oncomine Myeloid Assay GX v2 enables rapid, automated, and complete myeloid genomic profiling.

  • Broad mutation coverage for myeloid disease research: Detects SNVs, indels, ITDs, PTDs, and fusions across genes relevant to AML, MDS, MPN, CML and related disorders, supporting integrated genomic characterization
  • Minimal sample requirements: Requires only 20 ng DNA and 10 ng RNA
  • Fast results: Delivers resutls in as little as 24 hours
  • Automated workflow: Consolidating myeloid profiling with both DNA and RNA targets in one automated, sample-to-report workflow
  • Streamlined workflow for specialized labs: Optimized for hematology labs seeking efficient, standardized testing with the ability to handle bone marrow or blood samples

Custom NGS solutions

If you do not see an Oncomine assay or panel that fits your needs, custom Ion AmpliSeq panels can help support projects ranging from a few regions to hundreds of targets. Create your own designs using the Ion AmpliSeq Designer online tool. This free online tool makes it easy to design customized AmpliSeq panels to meet your unique targeted NGS testing needs. Simply sign in and design your custom targeted NGS panel in minutes - no prior sequencing experience needed.


Service and support

Thermo Fisher Scientific supports Oncomine Solutions users with services designed to help laboratories implement, optimize, and sustain rapid NGS workflows with confidence. Whether you are a new customer in need of instrument setup assistance, an established user looking to troubleshoot, add a new assay to your workflow, or perform an analytical validation, support is available across the journey.

 

Oncomine support includes:

 

Customer concierge services
A single point of contact to help coordinate readiness, delivery, installation, and training scheduling.

 

Analytical validation consultation
Guidance for RUO workflow implementation, including project management consultation, workflow training, optimization, and technical review consultation.

 

Comprehensive instrument service and support
ISO-certified field engineers, qualification services, maintenance, and remote support.

 

Oncology application consultants
Support from extraction to report, including application training, troubleshooting, and quality control support.

 

Bioinformatics experts
Setup, maintenance, software upgrades, data backup, and training for bioinformatics solutions.


Order Oncomine Assays on the Genexus System


Frequently asked questions

Rapid next-generation sequencing (NGS) refers to workflows that significantly reduce the time from sample to result—often delivering genomic insights within the next day. It integrates automated sample preparation, sequencing, and data analysis to accelerate oncology research.

End-to-end rapid NGS on the Genexus System means a fully automated workflow that takes you from biological sample to analyzed results with minimal hands-on time as fast as in 24 hours.

Oncomine Assays on the Genexus System can deliver results in as little as 24 hours, depending on the assay type and workflow configuration.

The Oncomine Comprehensive Assay v3 GX, Oncomine BRCA Assay GX and Oncomine Precision Assay GX are designed for solid tumor genomic profiling.

The Oncomine Comprehensive Assay Plus supports broad genomic profiling, covering a wide range of DNA and RNA biomarkers for deeper tumor characterization.

The Oncomine Myeloid Assay GX v2 is designed specifically for profiling myeloid malignancies, enabling detection of relevant mutations, fusions, and gene expression markers.

Yes. The Genexus workflow is designed for ease of use, with automation and pre-optimized protocols that reduce manual steps and training requirements, making it accessible for labs with limited NGS experience.

Yes. Custom NGS solutions are available, allowing laboratories to tailor panels or workflows based on specific clinical research needs. Thermo Fisher Scientific offers custom Ion AmpliSeq panels to help support projects ranging from a few regions to hundreds of targets.


Ready to speak to a Thermo Fisher Scientific representative?

We will be happy to answer your questions and provide a demo of our NGS solutions.

For Research Use Only. Not for use in diagnostic procedures.

PMR-005753